While JAK2 mutations primarily affect hematopoietic tissues, their impact can extend to other organs due to the systemic nature of the blood. Aberrant signaling can lead to symptoms such as splenomegaly, hepatomegaly, and extramedullary hematopoiesis, which can be identified through histological examination of affected tissues.
